Context Therapeutics stock price
NASDAQ:CNTX · Nasdaq · Healthcare · sector #16$0.2314-5.09%Oct 21 close · provisional
Loading chart…
Context Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is CNTX.
Context Therapeutics last closed at $0.2314 (-5.09%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -0.5×. Its overall grade ranks 683 of 726 stocks in Healthcare.
About this company
Context Therapeutics last closed at $0.2314 (-5.09%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 683/726
Valuation grade C+
Related stocks
- GSKCompetitor
- Bristol Myers SquibbCompetitor
- Merck & CoCompetitor
About Context Therapeutics
- What technical signals does Context Therapeutics (CNTX) have?
- Context Therapeutics current technical signals: no active technical signal.
- Is Context Therapeutics a cup-and-handle pattern?
- No. Context Therapeutics has no valid Cup signal right now.
- What published figures are available for Context Therapeutics?
- Market cap: $21.26M. Trailing 12 months PER: -0.5×. Latest quarter PBR: 0.61×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Context Therapeutics, or open the plan table on the main site.
Ask Q about Context Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy